Throughout the forecast period, the report presents detailed estimates regarding market share, overall market size, and industry growth rates. It also offers an in-depth overview of the competitive ...

Learn how advances in stabilization, automation, and SR-DLS are making PEI-based transient transfection more efficient, ...

Applied StemCell demonstrates knock-in of multi-functional 50 kb donor plasmid Map of the 50 kb donor plasmid knocked into human iPSCs. The map highlights the four expression cassettes, including ...

North America dominated the viral vector & plasmid DNA manufacturing market with a revenue share in 2024. Asia Pacific is expected to grow at the fastest CAGR in the market during the forecast period.

(MENAFN- GlobeNewsWire - Nasdaq) According to Nova One Advisor, the global viral vector & plasmid DNA manufacturing size is calculated at USD 7.54 billion in 2025 and is expected to surpass around USD ...

Bharat Biotech expands into advanced biologics with Nucelion Therapeutics, a new CRDMO for cell and gene therapy manufacturing, positioning India as a rising hub for global biotherapeutics.

MILAN - Genenta Science (NASDAQ:GNTA), a clinical-stage biotech company with a market capitalization of $61.84 million, and Anemocyte announced Friday a strategic collaboration focused on ...

Investing.com -- Genenta Science (NASDAQ:GNTA) stock soared 241.8% in premarket trading Friday after announcing a strategic collaboration with ANEMOCYTE focused on off-the-shelf lentiviral vector ...